---

Ophthalmology MBBS Exam Answer Prompt

---

PROMPT:

You are an MBBS university examination answer writer specializing in Ophthalmology. When given a question, write a complete, well-structured answer suitable for a university theory paper. Follow these rules strictly:

Format & Structure:

• Start with a definition (if applicable)
• Use headings and subheadings (e.g., Etiology, Pathophysiology, Clinical Features, Diagnosis, Treatment, Complications, Prognosis)
• Use numbered lists or bullet points for clarity
• Include a labeled diagram or diagram description where relevant (e.g., anatomy of the eye, surgical steps, optical diagrams)
• End with a short examiner's note or key point summary (2-3 lines) to leave a strong impression

Content Standards:

• Write at the level of a final-year MBBS student
• Cover both theory and clinical application (symptoms, signs, investigations, management)
• Mention eponyms, classifications, and grading systems where relevant (e.g., Snellen chart, Van Herick grading, Shaffer classification)
• Include drugs with doses for treatment questions (e.g., Timolol 0.5%, Atropine 1%)
• Reference standard ophthalmology textbooks (Kanski, A.K. Khurana, Parson's)

Marking Awareness:

• Allocate content proportional to marks (e.g., a 10-mark question needs ~2 pages; a 5-mark needs ~1 page)
• For short notes (5 marks): Definition + 4-5 key points + diagram
• For long questions (10 marks): Full systematic answer with all headings
• For clinical/case-based questions: Start with probable diagnosis, then justify with history/examination/investigations/management (HDIM framework)

Language & Presentation:

• Use clear, concise medical English
• Avoid vague statements - be specific (e.g., say "IOP > 21 mmHg" not "raised eye pressure")
• Bold or underline key terms as you would in a real exam

---

Now answer the following Ophthalmology question: [PASTE YOUR QUESTION HERE]

---

How to Use This Prompt

1. Copy the full prompt above
2. Replace [PASTE YOUR QUESTION HERE] with your actual question
3. Paste it into any AI (ChatGPT, Claude, etc.)

Example Questions to Test It With

---

---

GLAUCOMA

---

Definition

---

Classification

A. Based on Aetiology

B. Based on Anterior Chamber Angle (Gonioscopy)

1. Open-Angle Glaucoma - angle is open but drainage is impaired
2. Angle-Closure Glaucoma - iris blocks the trabecular meshwork

C. Common Types

• Primary Open-Angle Glaucoma (POAG) - most common type
• Primary Angle-Closure Glaucoma (PACG) - common in Asian populations
• Normal-Tension Glaucoma (NTG) - optic nerve damage despite IOP ≤ 21 mmHg
• Congenital/Infantile Glaucoma
• Secondary Glaucoma (pigmentary, pseudoexfoliative, steroid-induced, neovascular)

---

Epidemiology

• Affects 2-3% of people over 40 years of age
• Up to 50% remain undiagnosed
• Second leading cause of blindness worldwide (after cataract)
• POAG is most common in White and Black populations; PACG is most prevalent in people of East Asian descent

---

Aqueous Humour Dynamics (Pathophysiology)

1. Trabecular pathway (conventional) - 85-90% - through the trabecular meshwork into Schlemm's canal
2. Uveoscleral pathway (unconventional) - 10-15%

┌─────────────────────────────────────┐
│  Ciliary Body  →  Posterior Chamber │
│       ↓ (through pupil)             │
│  Anterior Chamber                   │
│       ↓                             │
│  Trabecular Meshwork                │
│       ↓                             │
│  Schlemm's Canal → Episcleral veins │
└─────────────────────────────────────┘

---

PRIMARY OPEN-ANGLE GLAUCOMA (POAG)

Risk Factors

1. Raised IOP - single most important modifiable risk factor; IOP >30 mmHg carries >40% 5-year risk
2. Age - prevalence increases with age
3. Race - 4x more common and more severe in Black populations
4. Family history - 4x risk in siblings, 2x risk in offspring of an affected individual
5. Myopia - increased susceptibility to glaucomatous damage
6. Genetics - mutations in MYOC gene (myocilin protein) and OPTN gene (optineurin) are established causes
7. Thin central corneal thickness (CCT) - increases risk
8. Low ocular perfusion pressure

Symptoms

• Usually asymptomatic until late stages (hence called the "silent thief of sight")
• Gradual visual field loss (peripheral first, central last)
• Normal visual acuity until advanced stages

Signs

• Increased cup-to-disc (C/D) ratio (>0.6, or asymmetry ≥0.2 between eyes)
• Loss of neuroretinal rim (NRR) - especially inferiorly then superiorly (ISNT rule violated: normal rim is Inferior > Superior > Nasal > Temporal)
• Notching of the rim (typically inferior or superior pole)
• Disc hemorrhages (Drance hemorrhage) - linear splinter-shaped at disc margin; indicates active progression
• Bayonetting of vessels at disc margin
• Peripapillary atrophy (beta zone)
• Nasalization of blood vessels

• Early: Paracentral scotoma, nasal step (Ronne's nasal step), temporal wedge
• Intermediate: Arcuate scotoma (Bjerrum's scotoma)
• Advanced: Ring scotoma, tubular vision (only central island remains), finally temporal island

---

Investigations / Workup

---

Medical Management

1st Line Drugs

2nd Line / Add-on Drugs

Key contraindications: Timolol is contraindicated in asthma, COPD, and bradycardia. Prostaglandins cause iris heterochromia and periorbital fat atrophy with long-term use.

---

Laser Treatment

1. Selective Laser Trabeculoplasty (SLT) - 1st line alternative to drops; stimulates trabecular cell phagocytosis
2. Argon Laser Trabeculoplasty (ALT) - older modality, limited re-treatment
3. Laser Peripheral Iridotomy (LPI) - for angle-closure; creates bypass channel in iris

---

Surgical Treatment

1. Trabeculectomy (Filtration Surgery - Gold Standard)

• Creates a bleb (subconjunctival reservoir) for aqueous drainage
• Antifibrotic agents: Mitomycin C (MMC) or 5-Fluorouracil (5-FU) used to prevent bleb scarring
• Complications: Hypotony, bleb leak, endophthalmitis, cataract

2. Glaucoma Drainage Devices (GDD)

• Ahmed Glaucoma Valve, Baerveldt implant - tube shunts
• Used in failed trabeculectomy or complex secondary glaucomas

3. Minimally Invasive Glaucoma Surgery (MIGS)

• iStent, Hydrus Microstent, Trabectome - angle-based procedures
• Lower risk profile; combined with cataract surgery

---

ACUTE ANGLE-CLOSURE GLAUCOMA (AACG) - High-Yield for Exams

Definition

Predisposing Factors

• Hypermetropia (shallow anterior chamber, short axial length)
• Female sex, older age, East Asian descent
• Precipitated by: dim illumination, mydriatics, anticholinergic drugs, emotional stress

Symptoms (Classic Triad)

1. Severe unilateral eye pain with periorbital headache
2. Blurred vision with coloured halos around lights
3. Nausea and vomiting

Signs (Classic Triad)

1. Corneal edema (steamy/hazy cornea)
2. Fixed, mid-dilated pupil (4-6 mm, oval, vertically elongated)
3. Conjunctival (ciliary) injection

• IOP is dramatically elevated (40-70 mmHg)
• Shallow anterior chamber
• Glaukomflecken (anterior subcapsular lens opacities from previous attacks)

Immediate Treatment

1. Acetazolamide 500 mg IV stat (or 250-500 mg oral)
2. Timolol 0.5% topical
3. Pilocarpine 2-4% topical (after IOP starts falling; miosis opens angle)
4. Mannitol 20% - 1-2 g/kg IV over 45 min (if refractory)
5. Brimonidine 0.1%, Dorzolamide 2% topical
6. Lie patient supine initially

---

Complications of Glaucoma

1. Blindness (irreversible)
2. Absolute glaucoma - painless blind eye with IOP persistently elevated
3. Phthisis bulbi in absolute glaucoma
4. Complications of surgery (hypotony, bleb infection, cataract, diplopia)

---

Diagram: Glaucomatous Optic Disc vs Normal

NORMAL DISC              GLAUCOMATOUS DISC
┌──────────┐             ┌──────────┐
│  ██████  │  NRR 360°   │  ░░░░░░  │  Cup enlarged
│ █ Cup █  │  C/D ~ 0.3  │ ░░ Cup ░░│  C/D > 0.6
│  ██████  │             │  ░░░░░░  │  Rim notched
│  ISNT    │             │  (Inferior│  inferiorly
│  rule ✓  │             │  notch)  │  NRR lost
└──────────┘             └──────────┘

---

Visual Field Progression Diagram

Early → Intermediate → Advanced
   •           ⌒             ◯
(paracentral) (arcuate)   (ring scotoma)
              scotoma
                          Tunnel vision → Total blindness

---

Examiner's Key Points

Remember: Glaucoma is the "silent thief of sight" - POAG is asymptomatic until 40% of nerve fibres are lost. The IOP normal range is 10-21 mmHg (mean 16 mmHg); diagnosis requires disc changes + visual field loss. Goldmann applanation tonometry is the gold standard for IOP measurement. LPI is the definitive treatment for AACG; trabeculectomy with MMC is the gold standard surgical procedure for POAG.

---

---

CORNEAL ULCER (SUPPURATIVE KERATITIS)

---

Definition

---

Anatomy Relevant to Corneal Ulcers

┌────────────────────────────────────────┐
│ 1. Epithelium (5-6 cell layers, 50 µm) │  ← Site of epithelial defect
│ 2. Bowman's layer (8-12 µm)            │  ← Does NOT regenerate if destroyed
│ 3. Stroma (500 µm, 90% of thickness)   │  ← Site of infiltrate/ulcer
│ 4. Descemet's membrane                 │  ← Descemetocele = imminent perforation
│ 5. Endothelium (single layer)          │  ← Pumps water out of stroma
└────────────────────────────────────────┘

---

Classification / Aetiology

A. Infective (Most Common)

B. Non-Infective

1. Neurotrophic ulcer - reduced corneal sensation (post-herpetic, CN V palsy)
2. Exposure keratopathy - lagophthalmos, CN VII palsy
3. Peripheral Ulcerative Keratitis (PUK) - autoimmune (RA, Wegener's granulomatosis)
4. Mooren's ulcer - idiopathic peripheral ulcer
5. Nutritional - Vitamin A deficiency (keratomalacia) - leading cause in developing countries

---

Predisposing / Risk Factors

1. Contact lens wear - single most important risk factor (especially extended-wear soft lenses; Pseudomonas responsible for >60%)
2. Corneal trauma - agricultural/vegetable matter injury (risk of fungal)
3. Dry eye / ocular surface disease
4. Systemic immunosuppression - diabetes, HIV, long-term steroids
5. Previous corneal surgery (LASIK, keratoplasty)
6. Malnutrition - Vitamin A deficiency
7. Lid abnormalities - entropion, trichiasis, lagophthalmos
8. Prior herpetic disease

---

Pathogenesis

1. Breach of epithelium (by trauma, desiccation, or infection) → loss of barrier function
2. Microbial adherence to exposed stroma
3. Stromal invasion with release of proteases and toxins
4. Recruitment of PMNs → inflammatory infiltrate (white/yellow opacity)
5. Progressive stromal necrosis and melting (proteolytic enzymes)
6. Hypopyon (sterile pus) forms from anterior chamber reaction
7. Descemetocele → perforation if untreated

Note: N. gonorrhoeae and H. influenzae can penetrate an intact corneal epithelium.

---

Clinical Features

Symptoms (Classic Four)

1. Ocular pain (severe; disproportionate pain suggests Acanthamoeba)
2. Photophobia and lacrimation
3. Blurred / decreased vision
4. Mucopurulent discharge

Signs

• Lid edema, conjunctival (ciliary/pericorneal) injection
• Mucopurulent discharge (bacterial); watery discharge (viral)

Characteristics by Organism

---

Investigations / Workup

Step 1: Corneal Scraping (Before Starting Treatment)

• Done with a sterile Kimura spatula or 23G needle under slit-lamp
• Multiple scrapings: for smear AND culture

Step 2: Smear Staining

Step 3: Culture Media

Step 4: Additional Investigations

• PCR - rapid, highly sensitive for HSV, Acanthamoeba
• In vivo confocal microscopy (IVCM) - visualizes Acanthamoeba cysts in real time without scraping
• B-scan ultrasonography - if posterior segment view is obscured
• Corneal topography - post-healing, to assess scarring and plan rehabilitation

---

Treatment

I. General / Supportive Measures

1. Cycloplegic drops (for pain relief and to prevent posterior synechiae):
   • Cyclopentolate 1% TDS
   • Atropine 1% BD-TDS (if hypopyon present or severe inflammation)
2. Analgesics - oral paracetamol/NSAIDs
3. Stop contact lenses immediately
4. Dark goggles for photophobia
5. No eye patching (creates warm anaerobic environment favoring bacterial growth)

---

II. Specific Anti-Infective Treatment

A. Bacterial Keratitis

• Ciprofloxacin 0.3% or Moxifloxacin 0.5% or Ofloxacin 0.3%
• Intensive regimen: q1h around the clock (loading dose q5min × 5 doses, then q30min until midnight, then q1h)

• Fortified Cefazolin 5% (50 mg/mL) q1h - for Gram-positive cover
• Fortified Gentamicin/Tobramycin 1.5% (15 mg/mL) q1h - for Gram-negative cover
• Alternate drops every 30 minutes (so one drop every 30 min overall)

• Prednisolone acetate 1% or Dexamethasone 0.1% QID
• Use cautiously - may cause corneal melting; avoid if significant thinning

• N. gonorrhoeae → Ceftriaxone 1g IM/IV stat
• Corneal perforation/threatened perforation → Ciprofloxacin oral + Doxycycline 100 mg BD (anticollagenase effect)

B. Fungal Keratitis

• Treatment duration: minimum 6-12 weeks (fungi grow slowly)
• Avoid topical steroids in fungal keratitis

C. Herpetic Keratitis (HSV)

CRITICAL: Never use topical steroids alone for HSV epithelial keratitis - causes geographic (amoeboid) ulceration and may lead to corneal perforation.

D. Acanthamoeba Keratitis

• Polyhexamethylene biguanide (PHMB) 0.02% + Propamidine isethionate (Brolene) 0.1% - q1h initially
• Alternative: Chlorhexidine 0.02% + Propamidine
• Treatment for minimum 3-6 months
• Avoid steroids until infection controlled
• Debridement of involved epithelium improves drug penetration

---

III. Surgical Management

1. Medical treatment fails
2. Corneal perforation occurs or is imminent
3. Residual scarring impairs vision

---

Complications

Local

1. Corneal perforation - most serious; risk of endophthalmitis
2. Corneal scarring / leucoma - permanent visual impairment
3. Descemetocele (bulging of Descemet's membrane)
4. Corneal vascularization (pannus)
5. Anterior synechiae (PAS) and secondary glaucoma
6. Hypopyon
7. Endophthalmitis - rare but devastating
8. Corneal ectasia / staphyloma (especially in children)

Systemic

• Spread of N. gonorrhoeae, N. meningitidis → life-threatening systemic sepsis

---

Prognosis

• Good prognosis: Small, peripheral, early-treated bacterial ulcers
• Poor prognosis: Central ulcers, fungal/Acanthamoeba, delayed treatment, perforation, immunosuppressed patients
• Final vision depends on: size, depth, location of residual scar; optical PKP may be needed later

---

Diagram: Slit-Lamp Appearance of Corneal Ulcer

ANTERIOR VIEW (Slit Lamp)         CROSS SECTION

   ____________                    Epithelium ══════ ← DEFECT (stains green)
  /  Conjunctival\                 Bowman's   ─ ─ ─ ─ 
 | injection ●●● |                 Stroma     ░░░░░░ ← INFILTRATE (white opacity)
 |   ┌────────┐  |                            ▓▓▓▓▓▓ ← NECROSIS
 |   │●ULCER ●│  |                 Descemet's ════════
 |   │(white) │  |                 Endothelium ────────
 |   └────────┘  |
  \_____________/                  ▲▲▲ HYPOPYON in AC
      Hypopyon                     (layered white cells)
   ═════════════
   (inferior AC)

---

Examiner's Key Points

Corneal ulcer is an ophthalmological emergency. The 3 key investigations are corneal scraping for smear + culture (before antibiotics), fluorescein staining (epithelial defect), and rose Bengal staining (virus-laden cells at ulcer margin in HSV). The classical eponyms to remember are: dendritic ulcer (HSV), serpiginous ulcer (Pneumococcus), Mooren's ulcer (idiopathic peripheral), and radial keratoneuritis (Acanthamoeba - virtually pathognomonic). Never patch a corneal ulcer and never use topical steroids in fungal or epithelial HSV keratitis.

---

CORNEAL ULCER — Quick Revision Sheet

---

Definition

---

Layers of Cornea (Mnemonic: "ESBDE")

Epithelium → Bowman's → Stroma (90%) → Descemet's → Endothelium

---

Types & Key Organisms

---

Risk Factors (Mnemonic: "CONTACTS")

Contact lens · Ocular trauma · Nutrition (Vit A) · Topical steroids abuse · Autoimmune · Compromised immunity · Trichiasis/lid problems · Surgery (LASIK)

---

Symptoms (All types)

---

Key Signs by Organism

---

Investigations (3 Steps)

• Fluorescein stain → epithelial defect (green)
• Rose Bengal → virus-laden cells at ulcer edge (HSV)
• Confocal microscopy → Acanthamoeba cysts (no scraping needed)

---

Treatment Summary

Always Start With:

• Cycloplegic (Atropine 1% BD or Cyclopentolate 1% TDS)
• Stop contact lenses · No patching · Dark glasses

Specific Drugs

Surgery (when medical fails)

• Cyanoacrylate glue → small perforation
• Tarsorrhaphy → neurotrophic/exposure
• Amniotic membrane → persistent epithelial defect
• Therapeutic PKP → uncontrolled infection / perforation
• Optical PKP → post-scar visual rehabilitation

---

Complications (Mnemonic: "SPAGHETTI")

Scar · Perforation · Anterior synechiae · Glaucoma · Hypopyon · Endophthalmitis · Thinning (ectasia) · Iritis

---

Eponyms to Remember

---

Golden Rules (Never Forget!)

❶ Never patch a corneal ulcer (anaerobic environment worsens infection) ❷ Never use steroids in fungal keratitis or HSV epithelial keratitis ❸ Scrape before treating — culture first, antibiotics second ❹ Acanthamoeba = pain disproportionate to signs = radial keratoneuritis ❺ Descemetocele = bulging Descemet's = imminent perforation → emergency surgery

---

---

PTERYGIUM

---

Definition

---

Etiology / Predisposing Factors

• UV radiation (most important) - common in equatorial/tropical regions
• Chronic ocular surface irritation (dust, wind, dryness)
• Familial tendency (autosomal dominant suggested)
• Outdoor occupation, fair skin

Histology: Elastotic degeneration of subepithelial collagen with vascular proliferation (same as pinguecula but extends onto cornea)

---

Parts of Pterygium (Diagram)

CORNEA          LIMBUS        CONJUNCTIVA
  ←─────────────────────────────────────
  [CAP]──[HEAD]──────[BODY]
    ↑        ↑           ↑
 Avascular  Stocker   Fleshy
  halo      Line      vascular
           (iron    triangular
        deposition)   wing

1. Cap - avascular grey halo at the advancing edge; Fuchs' islets present here
2. Head - apex on cornea; Stocker line (iron line) seen just anterior to it
3. Body - fleshy vascular triangular mass on conjunctiva

---

Clinical Features

Symptoms

• Small lesion → asymptomatic
• Irritation and grittiness (dellen effect at advancing edge)
• Blurred vision - if approaching visual axis or inducing irregular astigmatism
• Cosmetic blemish
• Intermittent redness and inflammation (pterygitis)

Signs

• Wing-shaped fibrovascular fold at 3 o'clock or 9 o'clock (nasal > temporal)
• Stocker line - brown iron line in corneal epithelium just ahead of the head
• Fuchs' islets - discrete white flecks at advancing edge (pterygial epithelial cells)
• Dellen - localized corneal drying/thinning adjacent to pterygium head
• Restricted ocular motility (if large/recurrent, subconjunctival fibrosis)

---

Pterygium vs Pseudopterygium

---

Treatment

A. Medical (Conservative)

1. UV-blocking sunglasses - slow progression
2. Artificial tears (preservative-free) 4-8× daily - lubrication, reduce irritation
3. Mild topical steroid (e.g., Fluorometholone 0.1% QID) or NSAID drops (Ketorolac 0.4% QID) for inflammation
4. No medical treatment stops growth - surgery is definitive

B. Indications for Surgery

1. Threatening the visual axis (approaching within 3 mm of centre)
2. Inducing significant astigmatism (>1.5 D)
3. Excessive irritation unresponsive to medical treatment
4. Cosmetic concern
5. Prior to cataract or refractive surgery

C. Surgical Techniques

Conjunctival autograft (from superior/upper-temporal limbal region, sutured with 10-0 nylon or tissue glue like TISSEEL fibrin glue) is the gold standard with lowest recurrence.

MMC reserved for recurrent pterygia due to risk of corneoscleral thinning/necrosis.

---

Complications

1. Recurrence after surgery (most common complication)
2. Irregular astigmatism - from corneal distortion
3. Visual axis encroachment - severe vision loss
4. Restricted ocular motility - from subconjunctival fibrosis (large/recurrent)
5. Dellen formation
6. Diplopia (post-surgical)
7. Corneoscleral necrosis - if MMC overused

---

Examiner's Key Points

Pterygium is a UV-induced fibrovascular degeneration with characteristic Stocker line and Fuchs' islets. The probe test distinguishes it from pseudopterygium (probe cannot pass under true pterygium). Bare sclera excision alone carries 80% recurrence - the gold standard treatment is conjunctival autograft, which reduces recurrence to ~5-10%. Intraoperative Mitomycin C is reserved for recurrent cases due to risk of scleral necrosis.

---

PTERYGIUM — Quick Revision Card

---

Definition

---

Cause (One Liner)

UV radiation + chronic surface irritation → elastotic degeneration of subepithelial collagen

---

3 Parts (Mnemonic: "CHB")

CAP → HEAD → BODY
(avascular)  (Stocker line here)  (vascular wing)

• Stocker line = iron line just ahead of head
• Fuchs' islets = white flecks at advancing edge

---

Symptoms (4 Ss)

Scratchiness · Seeing blurred · Sore/red · Stigmatism (astigmatism)

---

Key Sign

• Located at 3 or 9 o'clock (interpalpebral fissure)
• Probe test → cannot pass probe under body (distinguishes from pseudopterygium)

---

True vs Pseudo Pterygium

---

Treatment

Medical

• UV sunglasses + Artificial tears (lubricants)
• Inflamed → Fluorometholone 0.1% QID or Ketorolac 0.4% QID

Surgery — Indications ("VACC")

Visual axis threatened · Astigmatism >1.5D · Cosmesis · Contact lens intolerance

Surgical Options + Recurrence Rate

Graft sutured with 10-0 nylon or fibrin glue (TISSEEL)

---

Complications (5 Rs)

Recurrence · Refractive error (astigmatism) · Restricted motility · Red eye (dellen) · Risk of scleral necrosis (MMC)

---

Golden Rules

❶ Bare sclera alone = 80% recurrence — never do alone ❷ Conjunctival autograft = gold standard (lowest recurrence) ❸ MMC reserved for recurrent cases only (risk: scleral necrosis) ❹ Probe test = key to distinguish from pseudopterygium

---

---

CHALAZION AND STYE (HORDEOLUM)

---

Definitions

• External hordeolum (Stye) = infection of gland of Zeis or Moll (at lid margin)
• Internal hordeolum = infection of meibomian gland (deeper, points conjunctivally)
• Causative organism: Staphylococcus aureus (most common)

---

Comparison Table: Chalazion vs Stye

---

Anatomy of Eyelid Glands

UPPER EYELID - Cross Section

  Skin  →  Orbicularis  →  Tarsal plate  →  Conjunctiva
                               │
           ┌───────────────────┼───────────────────┐
           │                   │                   │
    Meibomian glands      Gland of Zeis       Gland of Moll
    (sebaceous; open     (modified sebaceous;  (modified sweat;
     at lid margin)      at lash follicle)     at lid margin)
           │                   │
        CHALAZION           EXTERNAL STYE
     (when blocked)         (when infected)

---

Clinical Features

Chalazion

• Gradual painless swelling in the eyelid (weeks to months)
• Heaviness or mild ache if large
• Blurred vision if large enough to press on cornea (induced astigmatism)
• Cosmetic concern

• Hard, non-tender, round nodule within tarsal plate
• Best seen on lid eversion - red/grey area on conjunctival surface
• Associated blepharitis or acne rosacea frequently present
• Conjunctival granuloma may develop if it points inward
• Madarosis (loss of lashes) if recurrent or near lid margin

Stye (External Hordeolum)

• Acute painful swelling at lid margin
• Redness, tenderness, watering

• Tender, red, pointing pustule at the base of a lash
• Yellow-white point of pus visible at the lash root
• Lid edema and conjunctival injection
• If internal: Painful swelling pointing through the conjunctival surface

---

Pathology

• Lipogranuloma - extracellular fat deposits surrounded by lipid-laden epithelioid cells, multinucleated giant cells, and lymphocytes
• No bacteria on culture

• Acute suppurative inflammation with PMN infiltration and abscess formation

Red Flag: A recurrent chalazion in the same site in an elderly patient must be biopsied to exclude sebaceous cell carcinoma (masquerade syndrome).

---

Investigations

• Usually a clinical diagnosis
• Slit-lamp examination - everted lid, blocked meibomian gland orifice
• Biopsy - mandatory for recurrent/atypical lesions (rule out sebaceous carcinoma)
• Culture and sensitivity - if associated preseptal cellulitis

---

Treatment

I. Conservative (Both Conditions - First Line)

1. Warm compresses × 10 minutes, 4 times daily + gentle lid massage
   • Liquefies inspissated secretions; aids drainage
2. Lid hygiene - clean lid margins with diluted baby shampoo daily
3. Observation - at least 1/3 of chalazia resolve spontaneously

II. Medical Treatment

III. Intralesional Steroid Injection (Chalazion)

• Triamcinolone acetonide 5 mg/mL - 0.2 to 1.0 mL injected into lesion
• Success rate ~80% after one injection; repeat in 1-2 weeks if needed
• Preferred for: marginal lesions, lesions near lacrimal punctum
• Complications: Skin depigmentation (especially in dark-skinned individuals), fat atrophy, rare central retinal artery occlusion (retrograde intra-arterial injection)

IV. Surgical: Incision and Curettage (I&C) - Definitive for Chalazion

STEPS OF I&C:
1. Topical + local anaesthetic infiltration
2. Evert eyelid with CHALAZION CLAMP
3. Vertical incision through tarsal plate on CONJUNCTIVAL SURFACE
4. Curette out lipogranulomatous contents
5. NO sutures required
6. Topical antibiotic (Chloramphenicol 0.5% or Tobramycin) TDS × 5 days
7. Send specimen for HISTOPATHOLOGY (mandatory)

Stye (External Hordeolum): If pointing - epilation of the causative eyelash allows spontaneous drainage. Incision and drainage only if abscess fluctuant.

---

Complications

---

Diagram: Stye vs Chalazion Location

EXTERNAL VIEW OF UPPER EYELID

LID MARGIN:  ─────[STYE]─────────
              ↑
        Base of lash
        (Gland of Zeis)

WITHIN LID:  ════[CHALAZION]═════
              ↑
        Tarsal plate
        (Meibomian gland)

ON EVERSION: Chalazion appears as
             RED/GREY nodule on
             CONJUNCTIVAL surface

---

Examiner's Key Points

Chalazion is a sterile lipogranuloma of the meibomian gland - treated conservatively first; if persistent, incision and curettage through the conjunctival surface (vertical incision through tarsal plate) is definitive. Stye is an acute S. aureus infection of the gland of Zeis at the lid margin - treated with warm compresses and topical antibiotics; epilation of the lash aids drainage. Always biopsy a recurrent chalazion in the same site in an elderly patient to exclude sebaceous cell carcinoma. Steroid injection (triamcinolone 5 mg/mL) is an effective alternative to surgery with ~80% success rate.

---

CHALAZION vs STYE — Quick Revision Card

---

One-Line Definitions

• Chalazion = Sterile lipogranuloma of Meibomian gland (chronic, painless)
• Stye = Acute S. aureus abscess of gland of Zeis at lid margin (painful)

---

Key Differences (Most Exam-Tested)

---

Anatomy (Quick Memory)

LID MARGIN → Stye (Gland of Zeis)
TARSAL PLATE → Chalazion (Meibomian gland)

---

Symptoms

---

Treatment

Chalazion

Stye

---

I&C Steps (4 Points)

1. LA infiltration → 2. Evert lid with chalazion clamp → 3. Vertical incision on conjunctival surface → 4. Curette + send for histopathology

---

Complications (4 Cs)

Cellulitis · Conjunctival granuloma · Corneal astigmatism · Carcinoma (sebaceous - if recurrent same site)

---

Golden Rules

❶ Chalazion = painless | Stye = painful — never confuse ❷ Recurrent chalazion same site in elderly = biopsy → rule out sebaceous carcinoma ❸ I&C incision is vertical, through conjunctival surface (not skin) ❹ Steroid injection complications: skin depigmentation + rare CRAO

---

---

CAVERNOUS SINUS THROMBOSIS (CST)

---

Definition

---

Anatomy of the Cavernous Sinus

┌─────────────────────────────────────────────┐
│         CAVERNOUS SINUS (Coronal View)       │
│                                             │
│  Lateral wall (superior → inferior):        │
│   CN III  (Oculomotor)    ─── Diplopia      │
│   CN IV   (Trochlear)     ─── Diplopia      │
│   CN V1   (Ophthalmic)    ─── Loss of       │
│   CN V2   (Maxillary)         facial         │
│                               sensation      │
│  Within the sinus:                          │
│   CN VI   (Abducens) ─── Most commonly      │
│   Internal Carotid Artery                   │
│                                             │
│  Drains: Ophthalmic veins, cerebral veins,  │
│          sphenoparietal sinus               │
└─────────────────────────────────────────────┘

Key fact: CN VI (abducens) lies within the sinus itself → earliest and most commonly affected nerve in CST (lateral rectus palsy → convergent squint).

---

Aetiology / Sources of Infection

Most Common: Septic (90%)

"Danger area of the face" = triangle between corners of mouth and nose bridge. Veins here drain via facial vein → ophthalmic veins → cavernous sinus (no valves = bidirectional flow). Never squeeze a boil in this area.

Aseptic (10%)

• Hypercoagulable states (malignancy, OCP use, dehydration, pregnancy)
• Trauma
• Post-surgical

---

Clinical Features

Systemic (Early)

• High spiking fever with rigors (septicaemia)
• Severe retro-orbital / frontal headache
• Malaise, nausea, vomiting
• Signs of meningeal irritation (neck stiffness, photophobia)
• Confusion, altered consciousness (late)

Ophthalmic Signs (Hallmark)

---

Investigations

---

Treatment

I. Immediate Hospitalisation (ICU/HDU level care)

II. Intravenous Antibiotics (Mainstay - for septic CST)

• Continue IV antibiotics for 3-6 weeks
• Adjust based on culture and sensitivity results

III. Anticoagulation (Controversial)

• Heparin (IV/LMWH) followed by Warfarin - used in aseptic CST
• May be considered in septic CST if no haemorrhage on imaging
• Decision made jointly with neurologist/internist

IV. Surgical Treatment

• Drainage of primary source (e.g., sphenoidal/ethmoidal sinus drainage, orbital abscess drainage)
• Neurosurgical drainage of thrombosed sinus (rarely needed)

V. Adjunct / Supportive

• IV fluids for hydration and haemodynamic support
• Analgesics for headache
• Anticonvulsants if seizures occur
• Lubricant eye drops (e.g., Carboxymethylcellulose) + taping of lids for exposure keratopathy (from proptosis + CN VII involvement)
• Treat secondary glaucoma (raised episcleral venous pressure)
• Corticosteroids - controversial; some use dexamethasone to reduce cerebral oedema

---

Complications

1. Blindness - CRVO, ischaemic optic neuropathy
2. Meningitis / brain abscess
3. Pituitary infarction (hypopituitarism)
4. Subdural empyema
5. Stroke - carotid artery thrombosis
6. Septicaemia / septic shock
7. Permanent CN palsies (diplopia, ptosis)
8. Death (20% with treatment; ~100% untreated)

---

Prognosis

• Mortality: 20-30% with treatment (adults); 10-20% in children
• Significant morbidity in survivors: permanent visual loss, CN palsies, hormonal deficiencies
• Early diagnosis and aggressive IV antibiotics are the single most important determinants of survival

---

Examiner's Key Points

Cavernous sinus thrombosis is diagnosed by bilateral proptosis + chemosis + ophthalmoplegia following a craniofacial infection - bilaterality distinguishes it from orbital cellulitis. CN VI palsy (lateral rectus) is the earliest sign as it lies free within the sinus. MRI venography is the gold standard for diagnosis. Treatment is urgent IV antibiotics (Ceftriaxone + Metronidazole ± Vancomycin) for 3-6 weeks; without treatment mortality approaches 100%. Never squeeze a boil in the "danger area of the face" as it can precipitate CST.

---

CAVERNOUS SINUS THROMBOSIS — Quick Revision Card

---

One-Line Definition

Septic/aseptic thrombosis of cavernous sinus → life-threatening emergency. Mortality 20% treated | ~100% untreated

---

What's Inside the Cavernous Sinus? (Mnemonic: "O TOM CAT")

---

Sources of Infection (Mnemonic: "FADES")

Face (boil/furuncle - danger area) · Acute sinusitis (sphenoid/ethmoid) · Dental abscess · Eye (orbital cellulitis) · Sinus/ear (otitis media)

Danger area of face = triangle: corners of mouth → bridge of nose → NEVER squeeze a boil here

---

Clinical Features (Mnemonic: "BCOP")

Bilateral proptosis + chemosis (key - differentiates from orbital cellulitis which is unilateral) CN palsies (III, IV, VI → ophthalmoplegia) Orbital pain + headache (retro-orbital, severe) Papilloedema + fever (spiking) + meningism

Progression

Unilateral → BILATERAL = ALARM SIGN (CST confirmed)

---

Investigations (3 Key)

---

Treatment (Mnemonic: "ABC")

---

Complications (5 Bs)

Blindness · Brain abscess · Bleeding (stroke) · Body (septicaemia) · Big mortality (death)

---

Golden Rules

❶ Bilateral proptosis + ophthalmoplegia = CST until proven otherwise ❷ CN VI palsy = earliest sign (abducens lies free within sinus) ❸ MRI venography = gold standard ❹ Never squeeze facial boil in danger area → can cause CST ❺ Delay = death — start IV antibiotics immediately

---

---

RED EYE

---

Definition

---

Types of Redness (Anatomical - Clinically Important)

TYPE              LOCATION           COLOUR        MOVEMENT
─────────────────────────────────────────────────────────────
Conjunctival    Superficial         Bright red    Moves with conjunctiva
(injection)     (peripheral more)

Ciliary flush   Around limbus       Violet-red    Does NOT move
(pericorneal)   (deep vessels)      (dusky)       → serious disease

Subconjunctival Between conjunctiva  Bright red    Flat sheet of blood
haemorrhage     and sclera          blotch        (no vessels visible)

Ciliary (pericorneal) flush = deep vessel engorgement = serious pathology (corneal ulcer, uveitis, acute glaucoma)

---

Classification / Causes of Red Eye

A. By Severity — Painless vs Painful

B. By Anatomical Layer (Systematic)

---

Differential Diagnosis — Key Comparison Table

---

Clinical Approach to Red Eye

History (Key Questions)

1. Pain? - Type: gritty vs aching vs severe shooting
2. Vision affected? - Normal vs blurred vs severely reduced
3. Discharge? - Purulent (bacterial) / watery (viral/allergic) / none
4. Itching? - Suggests allergic cause
5. Photophobia? - Suggests corneal/uveal involvement
6. Both eyes or one eye? - Bilateral = usually viral/allergic; unilateral = serious
7. Contact lens wear? - Risk for bacterial/Acanthamoeba keratitis
8. Recent trauma or surgery?
9. Systemic illness? - HLA-B27, RA, ankylosing spondylitis (uveitis)

Examination

1. Visual acuity (Snellen chart) - most important first step
2. Torch/pen light - type of injection, corneal clarity, pupil
3. Slit-lamp examination - cornea, AC, KPs, flare/cells, IOP
4. Fluorescein staining - corneal epithelial defect
5. Fundoscopy - if posterior segment involved
6. IOP measurement (Goldmann applanation tonometry)

---

Specific Conditions — Features & Treatment

1. Bacterial Conjunctivitis

• Signs: Mucopurulent discharge, conjunctival injection (peripheral), normal vision/pupil/cornea
• Treatment: Topical Ciprofloxacin 0.3% or Chloramphenicol 0.5% - QID × 5-7 days; Gentamicin 0.3% ointment BD

2. Viral Conjunctivitis (Adenovirus - most common)

• Signs: Watery discharge, preauricular lymphadenopathy, follicular reaction, unilateral onset then bilateral
• Treatment: Supportive - cold compresses, lubricants; highly contagious (hand hygiene)

3. Allergic Conjunctivitis

• Signs: Bilateral, marked itching, chemosis, papillary reaction; seasonal or perennial
• Treatment: Topical antihistamine (Olopatadine 0.1% BD) + mast cell stabiliser (Sodium cromoglicate 2% QID); avoid allergen

4. Anterior Uveitis (Iritis)

• Signs: Ciliary flush, small irregular pupil, keratic precipitates (KPs), cells/flare in AC, photophobia
• Treatment: Atropine 1% BD (cycloplegic) + Prednisolone acetate 1% QID (topical steroid)

5. Acute Angle-Closure Glaucoma

• Signs: Hazy cornea, fixed mid-dilated oval pupil, IOP >40 mmHg, coloured halos, severe pain + vomiting
• Treatment: Acetazolamide 500 mg IV stat + Timolol 0.5% + Pilocarpine 2-4% + Mannitol 20% IV if refractory; definitive = Laser Peripheral Iridotomy (LPI)

6. Subconjunctival Haemorrhage

• Signs: Bright red flat blotch, NO pain, normal vision, no discharge
• Cause: Valsalva (cough, sneeze), hypertension, anticoagulants, trauma
• Treatment: Reassurance - resolves in 1-2 weeks; investigate if recurrent (BP, bleeding disorder)

7. Episcleritis

• Signs: Sectoral redness, mild tenderness, normal vision; blanches with topical phenylephrine 10% (distinguishes from scleritis)
• Treatment: Usually self-limiting; topical NSAID (Ketorolac 0.5% QID) or mild steroid

8. Scleritis

• Signs: Deep, boring, excruciating pain (radiates to temple/jaw), violaceous hue, does NOT blanch with phenylephrine
• Associated with: RA, Wegener's granulomatosis, SLE
• Treatment: Oral NSAIDs (Indomethacin 25-50 mg TDS) + systemic immunosuppression if needed

---

Diagram: Red Eye — Approach Algorithm

                    RED EYE
                       │
          ┌────────────┴────────────┐
      PAINLESS                   PAINFUL
          │                         │
    ┌─────┴──────┐          ┌───────┴────────┐
Conjunctivitis  Sub-conj.  Vision Normal  Vision Reduced
(discharge+)  haemorrhage  (Ciliary flush) (Ciliary flush)
                │               │               │
           Reassurance     Uveitis/       Corneal ulcer/
                          Episcleritis   Acute Glaucoma
                               │               │
                          Slit lamp         URGENT
                          + IOP          REFER / ADMIT

---

Red Flags (Immediate Referral / Serious)

Any red eye with:

• Reduced vision
• Severe pain
• Ciliary (pericorneal) flush
• Fixed or irregular pupil
• Hazy cornea
• IOP >21 mmHg → Requires urgent ophthalmology referral

---

Examiner's Key Points

Red eye is a symptom, not a diagnosis. The two most important questions are: "Is vision affected?" and "Is there ciliary flush?" - a positive answer to either indicates serious pathology requiring urgent evaluation. The classic triad of ciliary flush + small irregular pupil + keratic precipitates = anterior uveitis; while hazy cornea + mid-dilated fixed oval pupil + very high IOP = acute angle-closure glaucoma - both require immediate treatment. Subconjunctival haemorrhage is the most benign cause - bright red, flat, painless, with normal vision - requires only reassurance.

---

RED EYE — Quick Revision Card

---

First, Ask 2 Questions (Most Important)

❶ Is vision reduced? ❷ Is there ciliary (pericorneal) flush? → YES to either = SERIOUS → Urgent referral

---

Types of Redness (Quick ID)

---

Master Comparison Table

---

Causes by Pain (Mnemonic: "PUCE-SAGA")

Pinguecula · Uveitis (mild) · Conjunctivitis · Episcleritis · Subconjunctival haemorrhage

Scleritis · Acute glaucoma · Glaucoma (corneal ulcer/keratitis) · Anterior uveitis

---

Treatment Summary

---

Red Flags — Refer Immediately if ANY of:

🔴 Reduced vision · Severe pain · Ciliary flush · Fixed/irregular pupil · Hazy cornea · IOP >21 mmHg

---

Golden Rules

❶ Ciliary flush = serious pathology (not simple conjunctivitis) ❷ Coloured halos + vomiting + hard eye = Acute Glaucoma → emergency ❸ Small irregular pupil + KPs = Uveitis → Atropine + steroids ❹ Flat red blotch, no pain, normal vision = Subconjunctival haemorrhage → reassure ❺ Episcleritis blanches with phenylephrine; Scleritis does NOT

---

GLAUCOMA — Complete LAQ Revision Card

---

Definition (1 Line)

Group of conditions with chronic progressive optic neuropathy → retinal ganglion cell death → visual field loss. IOP is the key modifiable risk factor. (Normal IOP = 10-21 mmHg)

---

Classification (Mnemonic: "PASCO")

---

Aqueous Flow (Must Draw!)

Ciliary body → Posterior chamber
      ↓ (through pupil)
Anterior chamber
      ↓
Trabecular meshwork → Schlemm's canal → Episcleral veins
      ↑
   BLOCK HERE = Raised IOP = Glaucoma

---

PRIMARY OPEN ANGLE GLAUCOMA (POAG)

Risk Factors (Mnemonic: "FAMILY")

Family history · Age (>40) · Myopia · IOP high · Large disc · Yellow race (Black population 4× risk)

Symptoms

NONE until late — "Silent thief of sight" Late: peripheral field loss → tunnel vision → blindness

Signs — Optic Disc Changes (Mnemonic: "CNBD")

ISNT Rule (Normal)

Inferior rim > Superior > Nasal > Temporal
(Violation of this rule = suspect glaucoma)

Visual Field Progression

Normal → Paracentral scotoma → Nasal step (Ronne's)
       → Arcuate/Bjerrum's scotoma → Ring scotoma
       → Tunnel vision → Blindness

---

Investigations (5 Key)

---

Medical Treatment (Step-ladder)

Timolol CI: Asthma, COPD, bradycardia Prostaglandins SE: Iris heterochromia, lash growth, periorbital fat loss

---

Laser Treatment

---

Surgery

---

ACUTE ANGLE CLOSURE GLAUCOMA (AACG)

Predisposed Person

Hypermetropic, elderly, female, Asian — shallow AC, short axial length

Classic Symptoms (Triad)

❶ Severe unilateral eye pain + headache ❷ Coloured halos around lights ❸ Nausea & vomiting

Classic Signs (Triad)

❶ Hazy/steamy cornea (oedema) ❷ Fixed, mid-dilated, oval pupil (4-6mm) ❸ Ciliary flush + IOP 40-70 mmHg

Emergency Treatment (Mnemonic: "ATPMC")

---

Complications of Glaucoma

Blindness → Absolute glaucoma (blind, high IOP, no pain) → Phthisis bulbi (shrunken end-stage eye)

---

Key Eponyms

---

Golden Rules

❶ POAG = no symptoms until 40% nerve fibres lost — screen at risk patients ❷ IOP normal range 10-21 mmHg; NTG = glaucoma with normal IOP ❸ AACG = emergency — treat within hours or permanent blindness ❹ LPI = definitive for angle closure; trabeculectomy + MMC = gold standard surgery ❺ Prostaglandin (Latanoprost) = 1st line drops; Timolol = contraindicated in asthma ❻ OCT detects RNFL loss BEFORE visual field changes

---

---

MEDICO-SOCIAL CASE PRESENTATION

Hansen's Disease (Leprosy) with Lepra Reaction

---

I. IDENTIFICATION DATA

---

II. CHIEF COMPLAINTS

1. Multiple hypopigmented, flat skin lesions over back, axilla and left thigh — 7 months
2. Tingling sensation in both upper limbs — 7 months
3. Raised, red, painful lesion over medial aspect of left cubital region — 4 months
4. Multiple erythematous nodular lesions over dorsum of left hand — 3 months
5. Two episodes of spontaneous epistaxis — 1 month

---

III. HISTORY OF PRESENT ILLNESS

• 7 months ago: Small hypopigmented patch over back → gradually increased in number and size involving back, axilla, left thigh
• Simultaneously: Tingling in both upper limbs — insidious onset, slowly progressive
• 4 months ago: Raised, erythematous, painful lesion over medial left cubital region → multiple erythematous nodules over dorsum of left hand with intermittent itching
• 1 month ago: Two episodes of spontaneous epistaxis
• No history of fever, joint pain, eye complaints, weight loss, or constitutional symptoms
• No previous treatment for leprosy or chronic skin disease

---

IV. PAST HISTORY

• No similar illness in the past
• No history of Tuberculosis, Diabetes, Hypertension
• No previous hospitalization or long-term medication

---

V. FAMILY HISTORY

• Family of 4 members
• Father: diagnosed with Tuberculosis 1 year ago
• No known case of leprosy among family/household/neighborhood contacts
• No significant hereditary illness

---

VI. PERSONAL HISTORY

• Mixed diet; normal appetite
• Sleep occasionally disturbed due to itching
• Bowel and bladder habits normal
• No addictions

---

VII. SOCIOECONOMIC HISTORY

Family Composition

Income Analysis

Socioeconomic Classification

Socioeconomic Class: Upper Lower Class (Class IV)

---

VIII. ENVIRONMENTAL HISTORY

Environmental Risk Factors Present: Overcrowding, poor sanitation, shared toilet, open sewer - all favour transmission of communicable diseases including leprosy.

---

IX. EPIDEMIOLOGICAL HISTORY

• No known contact with diagnosed leprosy case
• Resides in densely populated urban slum
• No history of migration or occupational exposure
• Environmental factors favouring transmission: overcrowding + poor sanitation
• Presence of TB in father → suggests compromised household immunity and exposure to mycobacterial infection

---

X. GENERAL EXAMINATION

• Conscious, cooperative, well-oriented to time, place and person
• Build: Moderate; Nutrition: Fair
• No pallor, icterus, cyanosis, clubbing
• No lymphadenopathy
• No pedal edema
• Vitals stable
• No visible deformities

---

XI. LOCAL EXAMINATION

A. Skin Lesions

• Multiple hypopigmented, flat (macular) patches
• Size: ~10 × 7 cm
• Distribution: Back, Axilla, Left thigh
• Hypoesthetic (reduced sensation over lesions)

B. Sensory Examination

C. Nerve Examination

• Left ulnar nerve: Thickened + tender
• Peripheral nerve thickening = hallmark of leprosy

D. Lepra Reaction Lesions

• Raised, tender, erythematous lesion over left medial cubital region
• Multiple erythematous nodules over dorsum of left hand
• → Consistent with Type 1 (Reversal) Reaction or Erythema Nodosum Leprosum (ENL)

E. Motor Examination

• Grade IV/V muscle power in left upper limb
• Early motor involvement (ulnar nerve territory)

F. Deformities

• None at present (early stage)

---

XII. SYSTEMIC EXAMINATION

---

XIII. INVESTIGATIONS

Specific

Routine

• CBC (Hb, TLC, DLC), RBS, LFT, RFT, Urine R/E

---

XIV. PROVISIONAL DIAGNOSIS

Multibacillary Leprosy (Hansen's Disease) — Borderline Lepromatous (BL) type, with thickening of left ulnar nerve and features of Lepra Reaction (Type 1 or ENL)

Basis of Diagnosis:

Ridley-Jopling Classification:

TT ──── BT ──── BB ──── BL ──── LL
(Paucibacillary)    (Multibacillary)
                         ↑
                  Mrs. Durga (likely BL)

WHO Classification:

---

XV. MEDICO-SOCIAL DIAGNOSIS

A 30-year-old female homemaker of Upper Lower socioeconomic class (Modified Kuppuswamy Score 6), residing in an overcrowded urban slum with inadequate environmental sanitation in Navi Mumbai, presenting with Multibacillary Leprosy (Hansen's Disease) with peripheral neuropathy (left ulnar nerve), early motor weakness, and active Lepra Reaction, requiring immediate initiation of MB-MDT under NLEP, contact screening, disability prevention, and social rehabilitation.

---

XVI. TREATMENT PLAN

A. Specific Treatment — MB-MDT (As per NLEP/WHO)

B. Treatment of Lepra Reaction

Do NOT stop MDT during lepra reaction

---

XVII. PREVENTIVE AND PUBLIC HEALTH MEASURES

Primary Prevention

• BCG vaccination of household contacts (especially children)
• Health education on early recognition of symptoms
• Improved housing, sanitation and nutrition
• Chemoprophylaxis with single-dose Rifampicin for household contacts (per NLEP)

Secondary Prevention

• Early diagnosis via skin smear and biopsy
• Prompt initiation of MDT to reduce transmission
• Screening of all household contacts (4 members)
• Regular follow-up visits

Tertiary Prevention (Disability Prevention — Grade 0 → Grade 2 Prevention)

WHO Disability Grading

Mrs. Durga: Currently Grade 0-1 → Goal = prevent progression to Grade 2

---

XVIII. NOTIFICATION AND PROGRAMME

• Notify under NLEP (National Leprosy Eradication Programme) - mandatory
• Register at nearest Urban Leprosy Centre / Primary Health Centre
• Contact tracing of all 4 household members
• Ensure treatment completion and record cure
• Follow-up at: 1 month, 3 months, 6 months, 12 months (end of treatment)

---

XIX. PROGNOSIS

---

XX. EXAMINER'S KEY POINTS

Leprosy (Hansen's disease) is caused by Mycobacterium leprae - an obligate intracellular acid-fast bacillus with the longest incubation period (2-5 years). This case is Multibacillary (>5 lesions + multiple nerve involvement) requiring 12-month MB-MDT (Rifampicin + Clofazimine + Dapsone). The thickened peripheral nerve (left ulnar) is pathognomonic of leprosy. Lepra reactions must be treated with steroids without stopping MDT. The social dimension - overcrowding, poverty, shared sanitation - underscores the need for both individual treatment and community-level public health intervention under NLEP.

---

---

MEDICO-SOCIAL CASE PRESENTATION

Department of Community Medicine

Case of Mrs. Durga Anil Shinde

---

---

INTRODUCTION

---

IDENTIFYING THE PATIENT

---

THE PATIENT'S STORY — CHIEF COMPLAINTS

---

PAST AND FAMILY HISTORY

---

PERSONAL HISTORY

---

SOCIOECONOMIC AND ENVIRONMENTAL BACKGROUND

---

CLINICAL EXAMINATION

Skin Findings

Sensory Examination

Nerve Examination

Lepra Reaction Signs

Motor Examination

Deformities

---

INVESTIGATIONS PLANNED

---

PROVISIONAL AND MEDICO-SOCIAL DIAGNOSIS

Multibacillary Leprosy (Hansen's Disease) — likely Borderline Lepromatous type — with peripheral neuropathy involving the left ulnar nerve, early motor weakness, and active Lepra Reaction.

A 30-year-old female homemaker of Upper Lower socioeconomic class, residing in an overcrowded urban slum with inadequate environmental sanitation in Navi Mumbai, presenting with Multibacillary Hansen's Disease with left ulnar neuritis, early motor deficit, and Lepra Reaction — requiring immediate MB-MDT, contact screening, disability prevention, social support, and notification under the National Leprosy Eradication Programme.

---

TREATMENT PLAN

• Once monthly, under direct supervision: Rifampicin 600 mg and Clofazimine 300 mg
• Daily, self-administered: Dapsone 100 mg and Clofazimine 50 mg
• Duration: 12 months

---

PUBLIC HEALTH AND PREVENTIVE MEASURES

---

CONCLUSION

---

---

Tip for presenting: Speak slowly and clearly. Make eye contact with the faculty. Pause briefly after each section heading. Use your hands naturally when describing lesion locations. Refer to the patient as "Mrs. Durga" throughout — it makes the presentation feel human and respectful.

---

MEDICO-SOCIAL CASE PRESENTATION

Department of Community Medicine

---

---

THE PATIENT

---

HER STORY

---

ON EXAMINATION

---

DIAGNOSIS

Multibacillary Hansen's Disease (Leprosy) with left ulnar neuritis and active Lepra Reaction.

A 30-year-old female homemaker of Upper Lower socioeconomic class, living in an overcrowded urban slum with poor sanitation, presenting with Multibacillary Leprosy with nerve involvement and Lepra Reaction — requiring MDT, contact screening, disability prevention, and NLEP notification.

---

TREATMENT AND PUBLIC HEALTH ACTION

• Monthly supervised: Rifampicin 600 mg + Clofazimine 300 mg
• Daily self-administered: Dapsone 100 mg + Clofazimine 50 mg
• For 12 months

• Case notified under NLEP
• All 4 household contacts screened
• Single-dose Rifampicin chemoprophylaxis offered to eligible contacts
• Health education on treatment adherence and stigma reduction
• Self-care training for hands and feet to prevent disability

---

CLOSING STATEMENT

---

Reading time: ~4 minutes | Speak slowly, make eye contact, pause at each section.